Health and Healthcare
Major Pharma Short Interest Continues to Recede
Published:
Last Updated:
The short interest data have been released for the April 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug is approved or passes a clinical trial, there can be big upside.
The April 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
Pfizer Inc. (NYSE: PFE) saw its short interest fall sharply to 108.39 million shares from the previous 149.82 million. Shares of Pfizer closed Tuesday at $33.50, within a 52-week trading range of $28.25 to $36.46.
Merck & Co. Inc. (NYSE: MRK) saw a decrease in short interest to 27.68 million shares from 30.40 million in the previous period. Merck shares closed Tuesday at $54.68, in a 52-week range of $45.69 to $61.70.
Bristol-Myers Squibb Co. (NYSE: BMY) saw its short interest decrease to 19.64 million shares from the previous reading of 21.50 million. Shares closed Tuesday at $71.53, within a 52-week range of $51.82 to $73.06.
AbbVie Inc. (NYSE: ABBV) short interest decreased to 20.99 million shares, compared to the previous level of 21.76 million. Short interest has backed way off its highest level of the past year last May. Shares of AbbVie closed Tuesday at $63.74, in a 52-week trading range of $45.45 to $71.60.
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.